Portola Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PTLA
CUSIP
737010108
All holders as of
Q2 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q2 1 0 $0
2021 Q1 1 0 $0
2020 Q4 1 0 $0
2020 Q3 1 0 $0
2020 Q2 186 74.5 M $1.34 B
2020 Q1 207 78.4 M $560 M
2019 Q4 243 79.7 M $1.90 B
2019 Q3 230 79.2 M $2.12 B
2019 Q2 234 72.3 M $1.96 B
2019 Q1 229 69.4 M $2.41 B
2018 Q4 213 71.4 M $1.40 B
2018 Q3 226 72.0 M $1.92 B
2018 Q2 224 62.8 M $2.37 B
2018 Q1 207 57.7 M $1.88 B
2017 Q4 235 57.9 M $2.82 B
2017 Q3 240 57.8 M $3.12 B
2017 Q2 239 49.9 M $2.79 B
2017 Q1 199 49.6 M $1.94 B
2016 Q4 167 50.7 M $1.14 B
2016 Q3 162 50.2 M $1.14 B
2016 Q2 166 52.4 M $1.30 B
2016 Q1 194 53.4 M $1.09 B
2015 Q4 203 52.3 M $2.69 B
2015 Q3 179 50.8 M $2.20 B
2015 Q2 162 48.4 M $2.20 B
2015 Q1 163 47.9 M $1.82 B
2014 Q4 137 44.6 M $1.26 B
2014 Q3 113 38.9 M $983 M
2014 Q2 112 36.1 M $1.05 B
2014 Q1 102 33.3 M $863 M